An atlas of genetic influences on human blood metabolites

Shin et al., Nature Genetics, 2014 [ Article | SI Text ]

Locus 102: ABCC4 (13q32.1)

Meta-analysis summary statistics for associations meeting genome-wide significance
Lead SNPBiochemicalsEA/OANtotalEAFEffect (SE)PmetaDetails
rs9302065 X-12244--N-acetylcarnosine A/G 6279 0.37 0.022 (0.002) 1.17·10-19 show

EA = effect allele; OA = other allele; EAF = frequency of effect allele;

Summary of biological annotations
SNPrs9302065
Chromosomal locationChr13: 94,769,017 (13q32.1)
Gene (distance)ABCC4 (17,330)
Predicted causal geneunknown
Gene/protein classificationtransporter
Metabolite (Pathway)X-12244--N-acetylcarnosine (Dipeptide; Peptide)
Biochemical locus-metabolite relationshipX-12244 has been identified as N-acetylcarnosine
eQTL associations-

 

Medical information
Complex trait associations-
Known metabolite associations-
Inborn error of metabolism-

Pharmacological information
ChEMBL IDCHEMBL1743128
Drug information Substrates: Adefovir, tenofovir, cyclic AMP, dehydroepian- drosterone sulphate, methotrexate, topotecan, furosemide, cyclic GMP, bile acids plus glutathione. Inhibitors: Celecoxib, diclofenac (PMID: 20190787)

Locus information for top associated metabolite

HapMap2 imputation

Imputation HapMap

1KGP imputation

Imputation 1KGP

 

Network view
Association map